Evidence map›Paper›PMID 38114493›Full record

ArticleNature communications2023

Synaptic density affects clinical severity via network dysfunction in syndromes associated with frontotemporal lobar degeneration.

David J Whiteside, Negin Holland, Kamen A Tsvetanov, Elijah Mak, Maura Malpetti, George Savulich, P Simon Jones, Michelle Naessens, Matthew A Rouse, Tim D Fryer and 7 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Detecting neuroplastic effects induced by ketamine in healthy human subjects: A multimodal approach.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Synaptic changes in psychiatric and neurological disorders: state-of-the art of in vivo imaging.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

David J WhitesideDepartment of Clinical Neurosciences, University of Cambridge, Cambridge, UK. djw216@cam.ac.uk.ORCID 0000-0002-5890-9220
Negin HollandDepartment of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Kamen A TsvetanovMedical Research Council Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, UK.
Elijah MakDepartment of Psychiatry, University of Cambridge, Cambridge, UK.
Maura MalpettiDepartment of Clinical Neurosciences, University of Cambridge, Cambridge, UK.ORCID 0000-0001-8923-9656
George SavulichDepartment of Psychiatry, University of Cambridge, Cambridge, UK.ORCID 0000-0002-6513-5454
P Simon JonesDepartment of Clinical Neurosciences, University of Cambridge, Cambridge, UK.ORCID 0000-0001-9695-0702
Michelle NaessensMedical Research Council Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, UK.
Matthew A RouseMedical Research Council Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, UK.
Tim D FryerDepartment of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Young T HongDepartment of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Franklin I AigbirhioDepartment of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Eoin MulroyUCL Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.
Kailash P BhatiaUCL Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.
Timothy RittmanDepartment of Clinical Neurosciences, University of Cambridge, Cambridge, UK.ORCID 0000-0003-1063-6937
John T O'BrienCambridge University Hospitals NHS Foundation Trust, Cambridge, UK.ORCID 0000-0002-0837-5080
James B RoweDepartment of Clinical Neurosciences, University of Cambridge, Cambridge, UK.ORCID 0000-0001-7216-8679
University of Cambridge · GBMRC Cognition and Brain Sciences Unit · GBNational Hospital for Neurology and Neurosurgery · GBCambridge University Hospitals NHS Foundation Trust · GB

Funding

Medical Research Council MC_UU_00030/14Wellcome Trust
6 · The paper itself

Abstract

There is extensive synaptic loss from frontotemporal lobar degeneration, in preclinical models and human in vivo and post mortem studies. Understanding the consequences of synaptic loss for network function is important to support translational models and guide future therapeutic strategies. To examine this relationship, we recruited 55 participants with syndromes associated with frontotemporal lobar degeneration and 24 healthy controls. We measured synaptic density with positron emission tomography using the radioligand [

Indexed as

Frontotemporal DementiaFrontotemporal Lobar DegenerationBrainDiffusion Magnetic Resonance ImagingHumansMagnetic Resonance ImagingPositron-Emission TomographySyndrome

Identifiers

PMID38114493
PMCPMC10730886
OpenAlexW4390012017

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.